| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 82 |
| 1 | ADALIMUMAB | 73 |
| 2 | BEVACIZUMAB | 55 |
| 3 | CAPECITABINE | 53 |
| 4 | FLUOROURACIL | 52 |
| 5 | FLUOROURACIL CREAM, 0.5% | 52 |
| 6 | DOCETAXEL | 34 |
| 7 | DOCETAXEL ANHYDROUS | 34 |
| 8 | PEMBROLIZUMAB | 34 |
| 9 | TRASTUZUMAB | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONTRUZANT | 8 | 0.0153 |
| 1 | CARBON DIOXIDE | 1 | 0.0087 |
| 2 | DIMETICONE | 2 | 0.0071 |
| 3 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 3 | 0.0067 |
| 4 | 1169 HYDROGEN PEROXIDE SPRAY | 2 | 0.0065 |
| 5 | HYDROGEN PEROXIDE | 2 | 0.0061 |
| 6 | ANGIOTENSIN II | 1 | 0.0033 |
| 7 | OXALIPLATIN | 82 | 0.0011 |
| 8 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 9 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 45 | 0.0005 |
| 3 | Platinum-based Drug [EPC] | 118 | 0.0004 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 32 | 0.0004 |
| 5 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 104 | 0.0004 |
| 7 | Integrin Receptor Antagonist [EPC] | 32 | 0.0004 |
| 8 | Non-Standardized Insect Allergenic Extract [EPC] | 2 | 0.0003 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 59 | 0.0003 |